CLASS I Drug recall · Reported 28 Nov 2012 · FDA Enforcement Report

Hydrocodone Bitartrate and Acetaminophen Tablets USP, 10 mg recalled

Watson Laboratories is recalling Hydrocodone Bitartrate and Acetaminophen Tablets USP, 10 mg/ per, distributed nationwide in the US. The recall was initiated on 21 Sep 2012 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot #: 519406A, 521759A, Exp 04/14
Quantity recalled4,874 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-058-2013
FDA event ID
63246
Recalling firm
Watson Laboratories, Corona, CA
Classification
Class I
Status
Terminated
Recall initiated
21 Sep 2012
FDA classified
16 Nov 2012
Reported
28 Nov 2012
Type
Voluntary: Firm initiated
Customers notified by
Press Release
Reason category
Potency & Assay
Drug class
Pain Medication

Timeline

21 Sep 2012Recall initiated by company
16 Nov 2012Classified by FDA+56 days
28 Nov 2012Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Superpotent (Multiple Ingredient) Drug: There is the potential for oversized and superpotent tablets.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Hydrocodone Bitartrate and Acetaminophen Tablets USP, 10 mg/500 mg, 500-count Tablets per bottle, Rx only, Manufactured By: Watson Laboratories, Inc., Corona, CA 92880 USA, NDC 00591-0540-05.

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Superpotent (Multiple Ingredient) Drug: There is the potential for oversized and superpotent tablets.

Which lots are affected?

Lot #: 519406A, 521759A, Exp 04/14

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Watson Laboratories

All 22

Other Hydrocodone Bitartrate recalls

All 19
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIHydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg recalledHydrocodone Bitartrate And AcetaminophenAscent PharmaceuticalsPackaging DefectsNationwide
DrugCLASS IIIHydrocodone Bitartrate and Homatropine Methlybromide recalledHydrocodone Bitartrate And Homatropine MethylbromideKvk-TechPotency & AssayNationwide
DrugCLASS IIHydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg recalledAscent PharmaceuticalsOtherNationwide
DrugCLASS IIHydrocodone Bitartrate and Homatropine Methlybromide Oral recalledHydrocodone Bitartrate And Homatropine MethylbromideKvk-TechParticulate MatterNationwide
DrugCLASS IIHydrocodone Bitartrate and Homatropine Methylbromide Oral recalledTorrent PharmaSterilityNationwide